House Bill #5094 (2019)

AN ACT RELATING TO BUSINESSES AND PROFESSIONS - PHARMACEUTICAL COST TRANSPARENCY

Requires the identification of prescription drugs on which the state spends significant health care dollars due to increase in costs and requires the drug's manufacturers to provide relevant information and documentation to justify costs increases.

View full text
View status on official RI website

Subscribe to email updates


Votes

RIBIT does not have any votes for this legislation yet.
(Vote tracking on RIBIT is still a work-in-progress, so make sure to check the official RI website, too!)